Huaier Inhibits Gastric Cancer Growth and Hepatic Metastasis by Reducing Syntenin Expression and STAT3 Phosphorylation

Table 2

Correlations between the syntenin expression level and the clinicopathological features of GC patients.

Variables	Syntenin expression		Total	χ^2	value
	High	Low
Age (years)
≤65	44	43	87	4.170	0.041
>65	33	15	48
Sex
Female	21	15	36	0.034	0.854
Male	56	43	99
Borrmann type
I + II	41	37	78	1.508	0.219
III + IV	36	21	57
Lauren type
Intestinal GC	41	30	71	2.319	0.314
Diffuse GC	27	16	43
Mixed GC	9	12	21
Grade of differentiation
Well + moderate	42	31	73	0.016	0.899
Poor + not	35	27	62
T stage
T1	0	2	2	3.419	0.064
T2 + T3 + T4	77	56	133
N stage
N0	8	3	11	0.607	0.436
N1 + N2 + N3	69	55	124
M stage
M0	66	56	122	4.465	0.035
M1	11	2	13
TNM stage
I + II	5	12	17	6.057	0.014
III + IV	72	46	118
CEA (ng/ml)
≤5	56	43	99	0.034	0.854
>5	21	15	36
HER2
Negative	65	51	116	0.338	0.561
Positive	12	7	19
PD-L1
Negative	42	40	82	2.885	0.089
Positive	35	18	53

Statistically significant ().